Expo and conference
International Conference & Exhibition on Biologics and Biosimilars
Laboratory · Biochemistry · Pharmaceuticals
Key numbers
- Editions on record
- 1first in 2018
About International Conference & Exhibition on Biologics and Biosimilars
Biosimilars 2018 focuses on “Market Dynamics of Biosimilars: Perspectives of Payers and Prescribers”. This Biosimilars networking meeting focuses on the trends in the biosimilar markets from its launch to the present from the perspectives of the payers and the prescribers. The conference will discuss product development, analytical requirements, and regulatory standards. The conference will also discuss pharmacovigilance, post marketing surveillance, and post-approval clinical studies. Compliance with regulatory guidelines is critical to the successful development and commercial launch for biologics and biosimilars. Moreover, the fast-changing global regulatory environment, including the complexities of Brexit, along with emerging price competition will likely have a substantial impact on the market for biologics and biosimilars. Therefore, it is important to understand the current market and the legal and regulatory complexities through quality information exchange and networking between Key Opinion Leaders from around the globe.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2018 | 26–27 Mar 2018 | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is International Conference & Exhibition on Biologics and Biosimilars?
The next dates haven't been confirmed. The last edition we have on record was 26–27 Mar 2018.